Study Details
Full Title
EPG-HU1418-201: A Phase 2/3 Study to Characterize and Evaluate the Efficacy, Safety, and Tolerability of hu14.18K322A Treatment Given in Combination with Chemotherapy in Participants with High-Risk Neuroblastoma
Principal Investigator
Jessica
Sun
Protocol Number
PRO00119566
NCT ID
NA
Phase
II/III
Enrollment Status
Open to Enrollment